Driving Biopharmaceutical Advancements of Naturally Derived and Evidence Based Products
Who We Are
Avicanna is a Canadian commercial-stage biopharmaceutical company
Leading in cannabinoid research, development, and evidence-based products for the global consumer medical and pharmaceutical segments.
Corporate Overview
Proprietary portfolio products – across API, medical, cosmetics and nutraceutical segments
Commercial scale up phase – across 19 international markets
Established USDA organic certified vertical integration infrastructure – in Santa Marta, Colombia
JLABS @ Johnson & Johnson Innovation Centre graduate housed in the MaRS Discovery District
Canadian R&D and clinical infrastructure – in partnership with world-class institutions
24 proprietary SKUs commercialized – from the lab to medical and retail channels in Canada
Pharmaceutical pipeline – addressing neurological, dermatological and pain indications
Medical cannabis and wellness products – in commercial stage
CBD Cosmetics and skincare – in commercial stage
Pharmaceutical pipeline – in development stage
Active pharmaceutical ingredients (API) – in commercial stage
Commercial Pillars and Portfolio
Including cosmetics, medical cannabis, pharmaceuticals in addition to its raw material business unit across international markets.
Commercial Stage
Medical Cannabis and Wellness Products
Commercial Stage
CBD Cosmetics and Skincare
In Development and Registration Stage
Pharmaceutical Pipeline
Commercial Stage
Cannabinoid API
Industry Leading Scientific Platform
Setting the Standard in the Cannabinoid Industry on Advanced and Evidence-Based Products
Scientific Platform
Setting the Standard in the Cannabinoid Industry with Advanced and Evidence-Based Products
30+
10+
Scientists
9
7
Pending Patents
4
Health Canada Cannabis
Research Licenses to Avicanna
or Institutional Collaborators
World-class Institutional Collaborations
R&D and Clinical Partnerships Over the Past 4 Years
World-class Institutional Collaborations
20+ R&D, pre-clinical and research collaborations with Canada’s leading institutions and thought leaders since 2017
Clinical Development
Setting the Standard in the Cannabinoid Industry on Advanced and Evidence-Based Products
08.08.2021
Products & Pipeline
Serving the Global Marketplace with Proprietary Advanced Cannabinoid-Based Products
